Skip to main content

Advertisement

SpringerLink
Log in

Hair Cell Loss Induced by Sphingosine and a Sphingosine Kinase Inhibitor in the Rat Cochlea

  • Original Article
  • Published:
Neurotoxicity Research Aims and scope Submit manuscript

Abstract

Sphingolipid metabolites including ceramide, sphingosine (Sph), and sphingosine-1-phosphate (S1P) play important roles in the regulation of cell survival and death. Sphingosine kinase (Sk) phosphorylates Sph to S1P. Sk is reportedly overexpressed in various cancer cells, and Sk inhibitors are therefore a target of anti-tumor therapy. However, the effects of Sph and Sk inhibitors on cochlear hair cells were unknown. In the present study, expression of Sk isotypes in the cochlea was examined. In addition, the changes in Sk activity induced by cisplatin (CDDP) and the effects of an Sk inhibitor, Sph, and S1P on CDDP ototoxicity were investigated using tissue culture techniques. Cochleae were dissected from Sprague–Dawley rats on postnatal days 3–5. Organ of Corti explants were exposed to 5 μM CDDP for 48 h with or without the Sk inhibitor, Sph, or S1P. Both Sk1 and Sk2 were expressed in the normal cochlea. CDDP activated Sk. The Sk inhibitor itself caused hair cell loss at a high concentration, and at lower concentrations, it increased CDDP-induced hair cell loss. Sph itself also induced hair cell death and increased hair cell loss induced by CDDP. However, S1P decreased hair cell loss induced by CDDP. Sk inhibitor has the function by increasing ototoxic Sph and decreasing otoprotective S1P and therefore potentially causes ototoxicity. Consideration of the possibility of ototoxicity is required in the usage of Sk inhibitors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12

Similar content being viewed by others

References

  • Alemany R, van Koppen CJ, Danneberg K, Ter Braak M, Meyer ZuHeringdorf D (2007) Regulation and functional roles of sphingosine kinases. Naunyn Schmiedebergs Arch Pharmacol 374(5–6):413–428

    Article  PubMed  CAS  Google Scholar 

  • Alexander S, Min J, Alexander H (2006) Dictyostelium discoideum to human cells: pharmacogenetic studies demonstrate a role for sphingolipids in chemoresistance. Biochim Biophys Acta Gen Subj 1760(3):301–309

    Article  CAS  Google Scholar 

  • Bonhoure E, Pchejetski D, Aouali N, Morjani H, Levade T, Kohama T, Cuvillier O (2006) Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1. Leukemia 20(1):95–102

    Article  PubMed  CAS  Google Scholar 

  • Chi LN, Tabuchi K, Nakamagoe M, Nakayama M, Nishimura B, Hara A (2015) Ceramide/sphingomyelin cycle involvement in gentamicin-induced cochlear hair cell death. Arch Toxicol 89(3):415–421

    Article  CAS  Google Scholar 

  • Cho SY, Lee HJ, Jeong SJ, Lee HJ, Kim HS, Chen CY, Lee EO, Kim SH (2011) Sphingosine kinase 1 pathway is involved in melatonin-induced HIF-1α inactivation in hypoxic PC-3 prostate cancer cells. J Pineal Res 51(1):87–93

    Article  PubMed  CAS  Google Scholar 

  • Coleman B, Rickard NA, de Silva MG, Shepherd RK (2009) A protocol for cryoembedding the adult guinea pig cochlea for fluorescence immunohistology. J Neurosci Methods 176(2):144–151

    Article  PubMed  PubMed Central  Google Scholar 

  • Cuvillier O (2008) Downregulating sphingosine kinase-1 for cancer therapy. Expert Opin Ther Targets 12(8):1009–1020

    Article  PubMed  CAS  Google Scholar 

  • Cuvillier O, Levade T (2001) Sphingosine 1-phosphate antagonizes apoptosis of human leukemia cells by inhibiting release of cytochrome c and Smac/DIABLO from mitochondria. Blood 98(9):2828–2836

    Article  PubMed  CAS  Google Scholar 

  • Cuvillier O, Rosenthal DS, Smulson ME, Spiegel S (1998) Sphingosine 1-phosphate inhibits activation of caspases that cleave poly(ADP-ribose) polymerase and lamins during Fas- and ceramide- mediated apoptosis in Jurkat T-lymphocytes. J Biol Chem 273(5):2910–2916

    Article  PubMed  CAS  Google Scholar 

  • Cuvillier O, Edsall L, Spiegel S (2000) Involvement of sphingosine in mitochondria-dependent Fas-induced apoptosis of type II Jurkat T cells. J Biol Chem 275(21):15691–15700

    Article  PubMed  CAS  Google Scholar 

  • Cuvillier O, Nava VE, Murthy SK, Edsall LC, Levade T, Milstien S, Spiegel S (2001) Sphingosine generation, cytochrome c release, and activation of caspase-7 in doxorubicin-induced apoptosis of MCF7 breast adenocarcinoma cells. Cell Death Differ 8(2):162–171

    Article  PubMed  CAS  Google Scholar 

  • Dickson MA, Carvajal RD, Merrill AH Jr, Gonen M, Cane LM, Schwartz GK (2011) A phase I clinical Trial of Safingol in combination with Cisplatin in Advanced Solid Tumors. Clin Cancer Res 17(8):2484–2492

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Ding D, He J, Allman BL, Yu D, Jiang H, Seigel GM, Salvi RJ (2011) Cisplatin ototoxicity in rat cochlear organotypic cultures. Hear Res 282(1–2):196–203

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • French KJ, Schrecengost RS, Lee BD, Zhuang Y, Smith SN, Eberly JL, Yun JK, Smith CD (2003) Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res 63(18):5962–5969

    PubMed  CAS  Google Scholar 

  • French KJ, Upson JJ, Keller SN, Zhuang Y, Yun JK, Smith CD (2006) Antitumor activity of sphingosine kinase inhibitors. J Pharmacol Exp Ther 318(2):596–603

    Article  PubMed  CAS  Google Scholar 

  • Guan H, Liu L, Cai J, Liu J, Ye C, Li M, Li Y (2011a) Sphingosine kinase 1 is overexpressed and promotes proliferation in human thyroid cancer. Mol Endocrinol 25(11):1858–1866

    Article  PubMed  CAS  Google Scholar 

  • Guan H, Song L, Cai J, Huang Y, Wu J, Yuan J, Li J, Li M (2011b) Sphingosine kinase 1 regulates the Akt/FOXO3a/Bim pathway and contributes to apoptosis resistance in glioma cells. PLoS ONE 6(5):e19946. doi:10.1371/journal.pone.0019946

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Hait NC, Oskeritzian CA, Paugh SW, Milstien S, Spiegel S (2006) Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim Biophys Acta 1758(12):2016–2026

    Article  PubMed  CAS  Google Scholar 

  • Hait NC, Allegood J, Maceyka M, Strub GM, Harikumar KB, Singh SK, Luo C, Marmorstein R, Kordula T, Milstien S, Spiegel S (2009) Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 325(5945):1254–1257

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Hoshino T, Tabuchi K, Nishimura B, Tanaka S, Nakayama M, Ishii T, Warabi E, Yanagawa T, Shimizu R, Yamamoto M, Hara A (2011) Protective role of Nrf2 in age-related hearing loss and gentamicin ototoxicity. Biochem Biophys Res Commun 415(1):94–98

    Article  PubMed  CAS  Google Scholar 

  • Huwiler A, Kotelevets N, Xin C, Pastukhov O, Pfeilschifter J, Zangemeister-Wittke U (2011) Loss of sphingosine kinase-1 in carcinoma cells increases formation of reactive oxygen species and sensitivity to doxorubicin-induced DNA damage. Br J Pharmacol 162(2):532–543

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Igarashi N, Okada T, Hayashi S, Fujita T, Jahangeer S, Nakamura S (2003) Sphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis. J Biol Chem 278:46832–46839

    Article  PubMed  CAS  Google Scholar 

  • Ishitsuka A, Fujine E, Mizutani Y, Tawada C, Kanoh H, Banno Y, Seishima M (2014) FTY720 and cisplatin synergistically induce the death of cisplatin-resistant melanoma cells through the downregulation of the PI3K pathway and the decrease in epidermal growth factor receptor expression. Int J Mol Med 34(4):1169–1174

    PubMed  CAS  Google Scholar 

  • Kanno T, Nishizaki T (2011) Sphingosine induces apoptosis in hippocampal neurons and astrocytes by activating caspase-3/-9 via a mitochondrial pathway linked to SDK/14-3-3 protein/Bax/cytochrome c. J Cell Physiol 226(9):2329–2337

    Article  PubMed  CAS  Google Scholar 

  • Kedderis LB, Bozigian HP, Kleeman JM, Hall RL, Palmer TE, Harrison SD Jr, Susick RL Jr (1995) Toxicity of the protein kinase C inhibitor safingol administered alone and in combination with chemotherapeutic agents. Fundam Appl Toxicol 25(2):201–217

    Article  PubMed  CAS  Google Scholar 

  • Li W, Yu CP, Xia JT, Zhang L, Weng GX, Zheng HQ, Kong QL, Hu LJ, Zeng MS, Zeng YX, Li M, Li J, Song LB (2009) Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients. Clin Cancer Res 15(4):1393–1399

    Article  PubMed  CAS  Google Scholar 

  • Liu H, Sugiura M, Nava VE, Edsall LC, Kono K, Poulton S, Milstien S, Kohama T, Spiegel S (2000) Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J Biol Chem 275(26):19513–19520

    Article  PubMed  CAS  Google Scholar 

  • Liu H, Toman RE, Goparaju SK, Maceyka M, Nava VE, Sankala H, Payne SG, Bektas M, Ishii I, Chun J, Milstien S, Spiegel S (2003) Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis. J Biol Chem 278(41):40330–40336

    Article  PubMed  CAS  Google Scholar 

  • Liu G, Zheng H, Zhang Z, Wu Z, Xiong H, Li J, Song L (2010) Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy. BMC Cancer 16(10):495. doi:10.1186/1471-2407-10-495

    Article  Google Scholar 

  • Liu SQ, Huang JA, Qin MB, Su YJ, Lai MY, Jiang HX, Tang GD (2012) Sphingosine kinase 1 enhances colon cancer cell proliferation and invasion by upregulating the production of MMP-2/9 and uPA via MAPK pathways. Int J Colorectal Dis 27(12):1569–1578

    Article  PubMed  Google Scholar 

  • Liu Y, Zhu Z, Cai H, Liu Q, Zhou H, Zhu Z (2014) SKI-II reverses the chemoresistance of SGC7901/DDP gastric cancer cells. Oncol Lett 8(1):367–373

    PubMed  CAS  PubMed Central  Google Scholar 

  • Maceyka M, Payne SG, Milstien S, Spiegel S (2002) Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim Biophys Acta 1585(2–3):193–201

    Article  PubMed  CAS  Google Scholar 

  • Maceyka M, Harikumar KB, Milstien S, Spiegel S (2012) Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol 22(1):50–60

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Min J, Stegner A, Alexander H, Alexander S (2004) Overexpression of sphingosine- 1-phosphate lyase or inhibition of sphingosine kinase in Dictyostelium discoideum results in a selective increase in sensitivity to platinum based chemotherapy drugs. Eukaryot Cell 3(3):795–805

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Min J, Traynor D, Stegner AL, Zhang L, Hanigan MH, Alexander H, Alexander S (2005a) Sphingosine kinase regulates the sensitivity of Dictyostelium discoideum cells to the anticancer drug cisplatin. Eukaryot Cell 4(1):178–189

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Min J, Van Veldhoven PP, Zhang L, Hanigan MH, Alexander H, Alexander S (2005b) Sphingosine-1-phosphate lyase regulates sensitivity of human cells to select chemotherapy drugs in a p38-dependent manner. Mol Cancer Res 3(5):287–296

    Article  PubMed  CAS  Google Scholar 

  • Mizugishi K, Yamashita T, Olivera A, Miller GF, Spiegel S, Proia RL (2005) Essential role for sphingosine kinases in neural and vascular development. Mol Cell Biol 25(24):11113–11121

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Nakamagoe M, Tabuchi K, Uemaetomari I, Nishimura B, Hara A (2010) Estradiol protects the cochlea against gentamicin ototoxicity through inhibition of the JNK pathway. Hear Res 261(1–2):67–74

    Article  PubMed  CAS  Google Scholar 

  • Nakayama M, Tabuchi K, Hoshino T, Nakamagoe M, Nishimura B, Hara A (2014) The influence of sphingosine-1-phosphate receptor antagonists ongentamicin-induced hair cell loss of the rat cochlea. Neurosci Lett 561:91–95

    Article  PubMed  CAS  Google Scholar 

  • Nava VE, Hobson JP, Murthy S, Milstien S, Spiegel S (2002) Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells. Exp Cell Res 281(1):115–127

    Article  PubMed  CAS  Google Scholar 

  • Nikolova-Karakashian M, Merril AH Jr (2000) Ceramidases. Methods Enzymol 311:194–201

    Article  PubMed  CAS  Google Scholar 

  • Nikolova-Karakashian MN, Reid MB (2011) Sphingolipid metabolism, oxidant signaling, and contractile function of skeletal muscle. Antioxid Redox Signal 15(9):2501–2517

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Nishimura B, Tabuchi K, Nakamagoe M, Hara A (2010) The influences of sphingolipid metabolites on gentamicin-induced hair cell loss of the rat cochlea. Neurosci Lett 485(1):1–5

    Article  PubMed  CAS  Google Scholar 

  • Ogretmen B, Hannun YA (2004) Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer 4(8):604–616

    Article  PubMed  CAS  Google Scholar 

  • Okada T, Ding G, Sonoda H, Kajimoto T, Haga Y, Khosrowbeygi A, Gao S, Miwa N, Jahangeer S, Nakamura S (2005) Involvement of N-terminal-extended form of sphingosine kinase 2 in serum-dependent regulation of cell proliferation and apoptosis. J Biol Chem 280(43):36318–36325

    Article  PubMed  CAS  Google Scholar 

  • Olivera A, Kohama T, Edsall L, Nava V, Cuvillier O, Poulton S, Spiegel S (1999) Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. J Cell Biol 147(3):545–558

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Oskouian B, Saba JD (2010) Cancer treatment strategies targeting sphingolipid metabolism. Adv Exp Med Biol 688:185–205

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Payne SG, Milstien S, Spiegel S (2002) Sphingosine-1-phosphate: dual messenger functions. FEBS Lett 531(1):54–57

    Article  PubMed  CAS  Google Scholar 

  • Pchejetski D, Böhler T, Stebbing J, Waxman J (2011) Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer. Nat Rev Urol 8(10):569–678

    Article  PubMed  CAS  Google Scholar 

  • Phillips DC, Martin S, Doyle BT, Houghton JA (2007) Sphingosine-induced apoptosis in rhabdomyosarcoma cell lines is dependent on pre-mitochondrial Bax activation and post-mitochondrial caspases. Cancer Res 67(2):756–764

    Article  PubMed  CAS  Google Scholar 

  • Pitman MR, Pitson SM (2010) Inhibitors of the sphingosine kinase pathway as potential therapeutics. Curr Cancer Drug Targets 10(4):354–367

    Article  PubMed  CAS  Google Scholar 

  • Pitson SM (2011) Regulation of sphingosine kinase and sphingolipid signaling. Trends Biochem Sci 36(2):97–107

    Article  PubMed  CAS  Google Scholar 

  • Pyne S (2002) Cellular signaling by sphingosine and sphingosine 1-phosphate: their opposing roles in apoptosis. Subcell Biochem 36:245–268

    Article  PubMed  CAS  Google Scholar 

  • Pyne S, Bittman R, Pyne NJ (2011) Sphingosine kinase inhibitors and cancer: seeking the golden sword of Hercules. Cancer Res 71(21):6576–6582

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Reynolds CP, Maurer BJ, Kolesnick RN (2004) Ceramide synthesis and metabolism as a target for cancer therapy. Cancer Lett 206(2):169–180

    Article  PubMed  CAS  Google Scholar 

  • Rybak LP, Whitworth CA, Mukherjea D, Ramkumar V (2007) Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res 226(1–2):157–167

    Article  PubMed  CAS  Google Scholar 

  • Sobkowicz HM, Loftus JM, Slapnick SM (1993) Tissue culture of the organ of Corti. Acta Otolaryngol Suppl 502:3–36

    PubMed  CAS  Google Scholar 

  • Spiegel S (1999) Sphingosine 1-phosphate: a prototype of a new class of second messengers. J Leukoc Biol 65(3):341–344

    PubMed  CAS  Google Scholar 

  • Tabuchi K, Pak K, Chavez E, Ryan AF (2007) Role of inhibitor of apoptosis protein in gentamicin-induced cochlear hair cell damage. Neuroscience 149(1):213–222

    Article  PubMed  CAS  Google Scholar 

  • Taha TA, Hannun YA, Obeid LM (2006) Sphingosine kinase: biochemical and cellular regulation and role in disease. J Biochem Mol Biol 39(2):113–131

    Article  PubMed  CAS  Google Scholar 

  • Tanaka S, Hattori N, Ishikawa N, Shoda H, Takano A, Nishino R, Okada M, Arihiro K, Inai K, Hamada H, Yokoyama A, Kohno N (2012) Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer. Int J Cancer 130(2):377–387

    Article  PubMed  CAS  Google Scholar 

  • Tang Y, Xu X, Guo S, Zhang C, Tang Y, Tian Y, Ni B, Lu B, Wang H (2014) An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma. PLoS One 9(3):e91551. doi:10.1371/journal.pone.0091551

    Article  PubMed  PubMed Central  Google Scholar 

  • Van Brocklyn JR, Williams JB (2012) The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death. Comp Biochem Physiol B: Biochem Mol Biol 163(1):26–36

    Article  Google Scholar 

  • Van Brocklyn JR, Jackson CA, Pearl DK, Kotur MS, Snyder PJ, Prior TW (2005) Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines. J Neuropathol Exp Neurol 64(8):695–705

    Article  PubMed  Google Scholar 

  • Van de Water T, Ruben RJ (1974) Growth of the inner ear in organ culture. Ann Otol Rhinol Laryngol. 83(5 Pt 2 Suppl 14):1–16

    PubMed  Google Scholar 

  • Wattenberg BW, Pitson SM, Raben DM (2006) The sphingosine and diacylglycerol kinase superfamily of signaling kinases: localization as a key to signaling function. J Lipid Res 47(6):1128–1139

    Article  PubMed  CAS  Google Scholar 

  • Xia P, Gamble JR, Wang L, Pitson SM, Moretti PA, Wattenberg BW, D’Andrea RJ, Vadas MA (2000) An oncogenic role of sphingosine kinase. Curr Biol 10(23):1527–1530

    Article  PubMed  CAS  Google Scholar 

  • Young MM, Kester M, Wang HG (2013) Sphingolipids: regulators of crosstalk between apoptosis and autophagy. J Lipid Res 54(1):5–19

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references

Acknowledgments

This work was supported by a Grant-in-aid for Scientific Research (C) (No. 24592541) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. I would like to show my greatest appreciation to Dr. Masahiro Nakayama whose technical supports of inestimable value for my study.

Author information

Authors and Affiliations

  1. Department of Otolaryngology, Faculty of Medicine, University of Tsukuba, Tennodai 1-1-1, Tsukuba, 305-8576, Japan

    Kohsuke Tani, Keiji Tabuchi & Akira Hara

Authors
  1. Kohsuke Tani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Keiji Tabuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Akira Hara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Keiji Tabuchi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tani, K., Tabuchi, K. & Hara, A. Hair Cell Loss Induced by Sphingosine and a Sphingosine Kinase Inhibitor in the Rat Cochlea. Neurotox Res 29, 35–46 (2016). https://doi.org/10.1007/s12640-015-9563-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12640-015-9563-7

Keywords

Search

Navigation